ASP Isotopes Inc. announced that it has entered into a definitive securities purchase agreement to issue 8,459,093 shares at a price of $0.9105 per share for the gross proceeds of $7,702,004.1765, 1,190,239 shares at a price $0.9548 for the gross proceeds of $1,136,440.1972 and 303,178 shares at a price $0.96 for the gross proceeds of $291,050.88 for the total gross proceeds of $9,129,495.2537 on October 9, 2023. The transaction will include participation from returning investor Tees River Critical Resources Fund Limited, and multiple members of the company?s board of directors. As a part of the transaction, the company may a fee equal to 5.0% of the aggregate gross proceeds from the shares sold that is $456,474.7626.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.42 USD | -3.49% | -13.50% | +146.93% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+146.93% | 208M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- ASPI Stock
- News ASP Isotopes Inc.
- ASP Isotopes Inc. announced that it expects to receive $9.129495 million in funding from Tees River Critical Resources Fund Limited